Oberadilol

Oberadilol (CID-3047798) is an ACE2 receptor binding agent. Oberadilol binds to the human ACE2 receptor and SARS-CoV proteins (Spike S glycoprotein, protease) with a Kd of 23.18 mM for the SARS-CoV-2 main protease[1].

Product Specifications

CAS Number

[114856-44-9]

Product Name Alternative

CID-3047798

UNSPSC

12352005

Target

Angiotensin-converting Enzyme (ACE) ; SARS-CoV; Virus Protease

Related Pathways

Anti-infection; Metabolic Enzyme/Protease

Applications

COVID-19-anti-virus

Field of Research

Infection

Smiles

N#CC1=CC=C(Cl)C=C1OCC(O)CNC(C)(C)CNC2=CC=C(C(C(C)C3)=NNC3=O)C=C2

Molecular Formula

C25H30ClN5O3

Molecular Weight

483.99

References & Citations

[1]Srivastava A, et al. Exploring nature's bounty: identification of Withania somnifera as a promising source of therapeutic agents against COVID-19 by virtual screening and in silico evaluation. J Biomol Struct Dyn. 2022 Mar;40 (4) :1858-1908.